Healthcare
Elevance Health Inc.(ELV)
Live Price
Offline$399.44
-0.61% today
1Y Change
+7.50%
Window
Jun 25, 2025 โ Jun 15, 2026
- Market Cap
- $80.15B
- Revenue Growth
- +12.6%
- EPS Growth
- -2.4%
- Dividend Yield
- 1.9%
Coverage: 244 bars ยท Jun 25, 2025 โ Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Elevance Health Inc. (ELV) is a Healthcare stock with a market cap of $80.15B and listed on NYSE. The stock last traded around $399.44 and up 7.5% across the available one-year price window (Jun 25, 2025 โ Jun 15, 2026). Baseline metrics include revenue growth of +12.6%, EPS growth of -2.4%, a dividend yield of 1.9%. What stands out right now is revenue +12.6%, EPS -2.4%, free cash flow -30.3% with operating margin 3.8% and ROIC 7.9%. The dividend is present but secondary, with a yield around 1.9%. Valuation is more restrained than many high-expectation growth names at P/E 15.5 and price/sales 0.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines ELV price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+12.6% vs +7.6% peer median
Operating Margin
Below sector median
+3.8% vs +19.4% peer median
P/E
Below sector median
15.5 vs 36.3 peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2026 was reported on Apr 22, 2026, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at +12.6% and EPS is at -2.4%, with operating margin around 3.8%.
Shareholder return is still part of the story
The stock is still offering a dividend yield around 1.9%, which matters if the thesis depends on income as much as growth.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged +3.8% over the next 5 trading days and finished higher after 1 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2026 Apr 22, 2026 | โ | +5.5% | +14.8% | +20.7% |
2026 Jan 28, 2026 | +7.4% | +1.5% | -0.4% | -5.5% |
2025 Oct 21, 2025 | +22.3% | -1.3% | -3.0% | -7.2% |
Benchmark Edge
ELV vs SPY, QQQ, and Sector ETFs
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
ELV
โ
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
ELV Max Drawdown
-30.60%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for ELV and SPY.
Company Overview
Elevance Health Inc.
New York Stock Exchange
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
- Leadership
- Gail Koziara Boudreaux
- IPO Date
- Oct 30, 2001
- Employees
- 104.2k
- Street Address
- 220 Virginia Avenue
- Mailing
- Indianapolis, IN, 46204
- Region
- Indianapolis, IN, US
- Reporting Currency
- USD
- Investor Line
- 800 331 1476
- Last Updated
- Apr 28, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- 15.5
- EV/EBITDA
- 11.5
- Price/Sales
- 0.4
- Price/Book
- 1.9
Growth
- Revenue
- +12.6%
- EPS
- -2.4%
- Free Cash Flow
- -30.3%
Profitability
- Gross Margin
- 23.2%
- Operating Margin
- 3.8%
- Net Margin
- 2.6%
- ROE
- 12.0%
- ROIC
- 7.9%
Balance Sheet
- Debt/Equity
- 0.73
- Current Ratio
- 1.48
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.